Status:
RECRUITING
Analysis of the Impact of a Temporo-spatial Reorientation Tool on the Speed of Improvement of Confusional Syndrome
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Attention Disorder
Eligibility:
All Genders
75+ years
Brief Summary
Confusion syndrome is defined by attentional disorders and disorganization of cognitive functions that are acute and reversible. There are patient-specific predisposing factors and precipitating facto...
Eligibility Criteria
Inclusion
- Patient aged 75 and over
- Hospitalized at the HUS in the SMRG department during the period from January 1, 2021 to April 31, 2023
- Passed at least a 4AT during hospitalization
- Absence of written opposition in the patient's medical file (and/or their legal representative if applicable) to the reuse of their data for scientific research purposes.
Exclusion
- \- Presence of written opposition from the patient (and/or their legal representative if applicable) in their medical file.
Key Trial Info
Start Date :
October 24 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 24 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06498297
Start Date
October 24 2023
End Date
April 24 2025
Last Update
July 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Soins de Soins Médicaux et de Réadaptation - CHU de Strasbourg - France
Strasbourg, France, 67091